You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Seattle Genetics

Showing 26 - 50 of 1,107
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Immunodeficiency Virus Trial in Chicago (brentuximab vedotin, Placebo, ART)

Recruiting
  • Human Immunodeficiency Virus
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
Jul 29, 2022

HER2 Positive Breast Cancer Trial in United States (tucatinib, trastuzumab deruxtecan)

Recruiting
  • HER2 Positive Breast Cancer
  • Birmingham, Alabama
  • +32 more
Oct 26, 2022

Triple Negative Breast Tumors Trial in Worldwide (ladiratuzumab vedotin, Pembrolizumab)

Recruiting
  • Triple Negative Breast Neoplasms
  • Birmingham, Alabama
  • +49 more
Jan 4, 2023

EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type

Recruiting
  • Type1 Diabetes Mellitus
  • Beta Cell Loss and Immune Function
  • Immune Function with RNAseq
  • Hope, California
  • +3 more
Jun 1, 2022

Ovarian Tumors, Peritoneal Tumors, Fallopian Tube Tumors Trial in United States (SGN-B7H4V)

Recruiting
  • Ovarian Neoplasms
  • +9 more
  • Aurora, Colorado
  • +6 more
Aug 15, 2022

Patients With Peroxisome Biogenesis Disorders (PBD)

Recruiting
  • Peroxisome Biogenesis Disorder
  • +10 more
    • Montreal, Quebec, Canada
      Research Institute of the McGill University Health Center
    Jul 4, 2022

    Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in Worldwide (Oral rucaparib)

    Completed
    Has Results
    • Ovarian Cancer
    • +3 more
    • Oral rucaparib
    • Anchorage, Alaska
    • +74 more
    Jan 31, 2022

    NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

    Recruiting
    • Non-small Cell Lung Cancer
    • +11 more
    • Birmingham, Alabama
    • +32 more
    Jan 4, 2023

    Healthy Adults Trial in Seattle (Controlled feeding study of beef and/or pinto beans, Controlled feeding study of eggs and/or

    Not yet recruiting
    • Healthy Adults
    • Controlled feeding study of beef and/or pinto beans
    • Controlled feeding study of eggs and/or black beans
    • Seattle, Washington
      Fred Hutchinson Cancer Center
    Jan 19, 2023

    Carcinoma, Non-Small Cell Lung, HER2 Negative Breast Tumors, Ovarian Tumors Trial in Worldwide (SGN-STNV)

    Recruiting
    • Carcinoma, Non-Small Cell Lung
    • +11 more
    • Los Angeles, California
    • +16 more
    Aug 15, 2022

    Hodgkin Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin, vinblastine)

    Active, not recruiting
    • Hodgkin Lymphoma
    • brentuximab vedotin
    • +5 more
    • Fountain Valley, California
    • +75 more
    Dec 2, 2022

    Urothelial Carcinoma Trial in United States (disitamab vedotin, pembrolizumab)

    Recruiting
    • Urothelial Carcinoma
    • Los Angeles, California
    • +17 more
    Jan 3, 2023

    Progressive Familial Intrahepatic Cholestasis, Alagille Syndrome, Cholestatic Liver Disease Trial in Worldwide (Maralixibat)

    Recruiting
    • Progressive Familial Intrahepatic Cholestasis
    • +2 more
    • Los Angeles, California
    • +13 more
    Jul 18, 2022

    Colorectal Tumors Trial in United States (tucatinib, trastuzumab, bevacizumab)

    Recruiting
    • Colorectal Neoplasms
    • Anaheim, California
    • +13 more
    Aug 15, 2022

    Peripheral T-cell Lymphoma Trial in Worldwide (brentuximab vedotin, cyclophosphamide, doxorubicin)

    Recruiting
    • Peripheral T-cell Lymphoma
    • brentuximab vedotin
    • +3 more
    • Birmingham, Alabama
    • +45 more
    Jan 4, 2023

    NSCLC Trial (SGN-B6A, docetaxel)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Aug 21, 2023

    Angina CCS Classe II-IV - IMR, RFR, FFR,CFR Trial in Naples

    Active, not recruiting
    • Angina CCS Classe II-IV - IMR, RFR, FFR,CFR
      • Naples, Italy
        Federico II University of Naples
      Jan 9, 2023

      Progressive Familial Intrahepatic Cholestasis (PFIC) Trial in Worldwide (Maralixibat)

      Enrolling by invitation
      • Progressive Familial Intrahepatic Cholestasis (PFIC)
      • Los Angeles, California
      • +27 more
      Aug 15, 2022

      Uterine Tumors, Uterine Cervical Tumors, Biliary Tract Tumors Trial in Worldwide (tucatinib, trastuzumab, fulvestrant)

      Recruiting
      • Uterine Neoplasms
      • +5 more
      • Goodyear, Arizona
      • +63 more
      Aug 15, 2022

      Melanoma, Carcinoma, Non-Small- Cell Lung Trial in Worldwide (SEA-CD40, pembrolizumab, pemetrexed)

      Recruiting
      • Melanoma
      • Carcinoma, Non-Small- Cell Lung
      • Springdale, Arkansas
      • +18 more
      Mar 11, 2022

      Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Worldwide (tisotumab vedotin)

      Completed
      • Ovarian Cancer
      • +2 more
      • tisotumab vedotin
      • San Jose, California
      • +36 more
      Jul 8, 2022

      Idiopathic Dilated Cardiomyopathy Trial in United States (Family Heart Talk Booklet)

      Enrolling by invitation
      • Idiopathic Dilated Cardiomyopathy
      • Family Heart Talk Booklet
      • Birmingham, Alabama
      • +26 more
      Sep 19, 2022

      Barrett Esophagus Trial in France (Electronic chromoendoscopy, White light endoscopy with Seattle protocol)

      Recruiting
      • Barrett Esophagus
      • Electronic chromoendoscopy
      • White light endoscopy with Seattle protocol
      • Amiens, France
      • +14 more
      Nov 23, 2022

      Cholestatic Liver Disease Trial in Worldwide (Maralixibat)

      Active, not recruiting
      • Cholestatic Liver Disease
      • Los Angeles, California
      • +16 more
      Jan 19, 2022

      Mitochondrial Diseases, Mitochondrial Encephalomyopathy, Mitochondrial Encephalopathy Trial in Montréal (deoxycytidine and

      Recruiting
      • Mitochondrial Diseases
      • +4 more
      • deoxycytidine and deoxythymidine
      • MontrĂ©al, Quebec, Canada
        Research InstituMcGill University Health Centre - Children Hospi
      Jan 26, 2023